MAKES RAZADYNE

Barr Receives Approval for Generic Version of Razadyne(R) E... (st 28 2008 Barr announced that the U.S. ...)Biology NewsMedicine NewsBiology ProductsMedicine ProductsBiology DefinitionMedicine DefinitionBiology TechnologyMedicine TechnologyBiology DictionaryMedicine Dictionaryst 28 2008 Barr announced that the U.S. District Court for theDistr...In her ruling District Court Judge Robinson found that the '318 paten...Razadyne ER had annual sales of approximately $112 million for thetwe...About Barr Pharmaceuticals Inc. ...Barr Pharmaceuticals Inc. is a global specialty pharmaceutical compan...Barr Pharmaceuticals, Inc. is a global specialty pharmaceutical company that operates in more than 30 countries worldwide and is engaged in the development, manufacture and marketing of generic and proprietary pharmaceuticals, biopharmaceuticals and active pharmaceutical ingredients. A holding company, Barr operates through its principal subsidiaries: Barr Laboratories, Inc., Duramed Pharmaceuticals, Inc. and PLIVA d.d. and its subsidiaries. The Barr Group of companies markets more than 120 generic and 27 proprietary products in the U.S. and approximately 1,025 products globally outside of the U.S. For more information, visit http://www.barrlabs.com.